Correlation Between Gmo Core and Alger Health
Can any of the company-specific risk be diversified away by investing in both Gmo Core and Alger Health at the same time? Although using a correlation coefficient on its own may not help to predict future stock returns, this module helps to understand the diversifiable risk of combining Gmo Core and Alger Health into the same portfolio, which is an essential part of the fundamental portfolio management process.
By analyzing existing cross correlation between Gmo E Plus and Alger Health Sciences, you can compare the effects of market volatilities on Gmo Core and Alger Health and check how they will diversify away market risk if combined in the same portfolio for a given time horizon. You can also utilize pair trading strategies of matching a long position in Gmo Core with a short position of Alger Health. Check out your portfolio center. Please also check ongoing floating volatility patterns of Gmo Core and Alger Health.
Diversification Opportunities for Gmo Core and Alger Health
0.01 | Correlation Coefficient |
Significant diversification
The 3 months correlation between Gmo and Alger is 0.01. Overlapping area represents the amount of risk that can be diversified away by holding Gmo E Plus and Alger Health Sciences in the same portfolio, assuming nothing else is changed. The correlation between historical prices or returns on Alger Health Sciences and Gmo Core is a relative statistical measure of the degree to which these equity instruments tend to move together. The correlation coefficient measures the extent to which returns on Gmo E Plus are associated (or correlated) with Alger Health. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when the price movement of Alger Health Sciences has no effect on the direction of Gmo Core i.e., Gmo Core and Alger Health go up and down completely randomly.
Pair Corralation between Gmo Core and Alger Health
Assuming the 90 days horizon Gmo E Plus is expected to generate 0.23 times more return on investment than Alger Health. However, Gmo E Plus is 4.43 times less risky than Alger Health. It trades about 0.31 of its potential returns per unit of risk. Alger Health Sciences is currently generating about -0.28 per unit of risk. If you would invest 1,708 in Gmo E Plus on November 29, 2024 and sell it today you would earn a total of 34.00 from holding Gmo E Plus or generate 1.99% return on investment over 90 days.
Time Period | 3 Months [change] |
Direction | Moves Together |
Strength | Insignificant |
Accuracy | 100.0% |
Values | Daily Returns |
Gmo E Plus vs. Alger Health Sciences
Performance |
Timeline |
Gmo E Plus |
Alger Health Sciences |
Gmo Core and Alger Health Volatility Contrast
Predicted Return Density |
Returns |
Pair Trading with Gmo Core and Alger Health
The main advantage of trading using opposite Gmo Core and Alger Health positions is that it hedges away some unsystematic risk. Because of two separate transactions, even if Gmo Core position performs unexpectedly, Alger Health can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in Alger Health will offset losses from the drop in Alger Health's long position.Gmo Core vs. Tax Managed Large Cap | Gmo Core vs. Fisher Large Cap | Gmo Core vs. Jpmorgan Large Cap | Gmo Core vs. Guidemark Large Cap |
Alger Health vs. Goldman Sachs High | Alger Health vs. Intal High Relative | Alger Health vs. Virtus High Yield | Alger Health vs. Access Flex High |
Check out your portfolio center.Note that this page's information should be used as a complementary analysis to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the Price Ceiling Movement module to calculate and plot Price Ceiling Movement for different equity instruments.
Other Complementary Tools
Odds Of Bankruptcy Get analysis of equity chance of financial distress in the next 2 years | |
Bonds Directory Find actively traded corporate debentures issued by US companies | |
Fundamental Analysis View fundamental data based on most recent published financial statements | |
Commodity Directory Find actively traded commodities issued by global exchanges | |
Equity Analysis Research over 250,000 global equities including funds, stocks and ETFs to find investment opportunities |